ID: h-SDA-2026-04-26-gap-debate-20260426-011
Hypothesis

Soluble LRP1 (sLRP1) Ectodomain Shedding as a Blood-Based Indicator of Impaired Aβ Clearance Across the BBB

LRP1 mediates Aβ export from brain to blood at the BBB.
🧬 LRP1 (LDL Receptor Related Protein 1)🎯 Composite 68%💱 $0.58▼11.1%proposed
neurodegeneration
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.78 (15%) Evidence 0.52 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.70 (5%) KG Connect 0.50 (8%) 0.680 composite

🧪 Overview

LRP1 mediates Aβ export from brain to blood at the BBB. Metalloprotease-mediated shedding of the LRP1 ectodomain (sLRP1) generates circulating fragments that retain Aβ-binding capacity but lack transmembrane signaling. Elevated sLRP1 indicates LRP1 dysfunction and impaired Aβ clearance, occurring before amyloid plaque formation. This hypothesis links Aβ clearance mechanisms directly to BBB dysfunction.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
A["Metalloprotease Activation"] --> B["LRP1 Ectodomain Shedding"]
B --> C["sLRP1 Elevation in Blood"]
C --> D["LRP1 Dysfunction at BBB"]
D --> E["Impaired Abeta Transcytosis"]
E --> F["Reduced Abeta Clearance from Brain"]
F --> G["Abeta Accumulation in Brain"]
D --> H["BBB Endothelial Dysfunction"]
G --> I["Amyloid Plaque Formation"]
H --> I
G --> J["Neuronal Toxicity"]
J --> K["Cognitive Decline"]
I --> K
F --> J
G["Abeta Accumulation in Brain"] --> L["Memory Impairment"]
K["Cognitive Decline"] --> M["AD Progression"]

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
sLRP1 elevation in AD correlates with cognitive decline
Supports
LRP1 mediates Aβ transcytosis across BBB
Supports
LRP1 deficiency causes Aβ accumulation in brain endothelium
Contradicts
Source of circulating sLRP1 not specifically attributed to brain endothelium
Contradicts
Soluble fragments may have different functional implications than membrane-bound LRP1
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — LRP1

🧬 PDB 2FCW Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for LRP1 (LDL Receptor Related Protein 1) from GTEx v10.

Cerebellum128 Cerebellar Hemisphere98.4 Cortex50.3 Nucleus accumbens basal ganglia47.9 Frontal Cortex BA941.7 Caudate basal ganglia41.7 Anterior cingulate cortex BA2437.8 Putamen basal ganglia33.6 Amygdala32.3 Hypothalamus31.3 Substantia nigra29.2 Hippocampus25.5 Spinal cord cervical c-117.7median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for LRP1 (LDL Receptor Related Protein 1) →

No DepMap CRISPR Chronos data found for LRP1 (LDL Receptor Related Protein 1).

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.7%
Volatility
Medium
0.0206
Events (7d)
2
Price History
▼11.1%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations1 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
If soluble LRP1 (sLRP1) ectodomain shedding indicates impaired LRP1-mediated Aβ clearance at the BBB, then elevated plasma sLRP1 will predict reduced CSF/plasma Aβ42 ratio and slower Aβ clearance rateIn AD/MCI patients (n≥80), high plasma sLRP1 (top quartile) correlates with reduced CSF/plasma Aβ42 ratio (r<-0.45), decreased peripheral Aβ clearance rate (40-— no observation —pending0.73
🔮 Falsifiable Predictions (1)
pendingconf —
If soluble LRP1 (sLRP1) ectodomain shedding indicates impaired LRP1-mediated Aβ clearance at the BBB, then elevated plasma sLRP1 will predict reduced CSF/plasma Aβ42 ratio and slower Aβ clearance rates, independent of amyloid production and systemic LRP1 expression.
Predicted outcome: In AD/MCI patients (n≥80), high plasma sLRP1 (top quartile) correlates with reduced CSF/plasma Aβ42 ratio (r<-0.45), decreased peripheral Aβ clearance
Falsification: sLRP1 elevation does not correlate with Aβ clearance or CSF/plasma Aβ42 ratio; sLRP1 levels are explained entirely by systemic LRP1 expression changes and do not reflect BBB LRP1 function.
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.